HOXB7 and ovarian carcinoma: In ovarian cancer cells, the expression of miR-513a-3p is significantly decreased, miR-513a-3p inhibits epithelial–mesenchymal transition and promotes sensitivity of ovarian cancer cells to cisplatin by targeting HOXB7 [22].